These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26073325)

  • 41. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
    Jiang W; Zhang C; Tian Z; Zhang J
    Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular carcinoma after direct-acting antivirals for hepatitis C is associated with KIR-HLA types predicting weak NK cell-mediated immunity.
    Ryan JC; Haight C; Niemi EC; Grab JD; Dodge JL; Lanier LL; Monto A
    Eur J Immunol; 2024 Aug; 54(8):e2350678. PubMed ID: 38700055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TIGIT
    Yu L; Liu X; Wang X; Yan F; Wang P; Jiang Y; Du J; Yang Z
    Oncoimmunology; 2021; 10(1):1942673. PubMed ID: 34249476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma.
    Tatsumi T; Takehara T
    Hepatol Res; 2016 Mar; 46(5):416-22. PubMed ID: 26574168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
    Arzumanyan A; Reis HM; Feitelson MA
    Nat Rev Cancer; 2013 Feb; 13(2):123-35. PubMed ID: 23344543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
    Yu M; Luo H; Fan M; Wu X; Shi B; Di S; Liu Y; Pan Z; Jiang H; Li Z
    Mol Ther; 2018 Feb; 26(2):366-378. PubMed ID: 29339014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.
    Goto K; Annan DA; Morita T; Li W; Muroyama R; Matsubara Y; Ito S; Nakagawa R; Tanoue Y; Jinushi M; Kato N
    Sci Rep; 2016 Dec; 6():38407. PubMed ID: 27910927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
    Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
    Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene therapy for HCV/HBV-induced hepatocellular carcinoma.
    Smerdou C; Menne S; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1368-77. PubMed ID: 21154119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Cho HJ; Cheong JY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma.
    Kitahara M; Mizukoshi E; Nakamoto Y; Mukaida N; Matsushima K; Kaneko S
    Int Immunopharmacol; 2014 Aug; 21(2):346-53. PubMed ID: 24893118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.